Latest News
Conference Coverage
Third course of alemtuzumab can improve MS outcomes
SAN DIEGO – Patients who experience radiographic relapse after two courses of alemtuzumab may not be treatment failures.
Conference Coverage
Switching RRMS patients to daclizumab beta appears safe
SAN DIEGO – A post hoc analysis from the DECIDE study sheds light on the efficacy of transitioning patients from glatiramer acetate to daclizumab...
Conference Coverage
VIDEO: Efficacy of DMTs decreases with age
SAN DIEGO – A meta-analysis offers new insights into the age-dependent efficacy of multiple sclerosis treatments.
Conference Coverage
VIDEO: New MS ambulatory measure could fill clinical gap
SAN DIEGO – Dr. Emily Evans explains how the single-item instruments measure up to existing ambulatory scales.
Conference Coverage
VIDEO: Alemtuzumab associated with long-term MS control in TOPAZ study
SAN DIEGO – Extension study reveals durable benefit at 7 years.
Conference Coverage
Ibudilast shows promise in progressive MS
SAN DIEGO – Imaging results proved favorable, and clinical endpoints will be forthcoming.
Conference Coverage
MS may be a transmissible protein misfolding disorder, study suggests
SAN DIEGO – Researchers transmit condition to transgenic mice via injections of human brain matter.
Conference Coverage
VIDEO: Could targeting gut dysbiosis in MS prevent disease?
SAN DIEGO – Transgenic mouse studies lead to questions of altering gut flora to prevent disease in people at high risk for multiple sclerosis.
Conference Coverage
Ticagrelor may be superior to clopidogrel in poor metabolizers
LOS ANGELES – Combined with aspirin, ticagrelor led to better platelet outcomes than did clopidogrel, but clinical outcomes only trended toward an...
Conference Coverage
Tenecteplase surpasses alteplase for thrombolysing acute ischemic stroke
LOS ANGELES – In a randomized study with 202 acute ischemic stroke patients, treatment with tenecteplase produced better reperfusion than did...
Conference Coverage
Rituximab fails to eliminate meningeal inflammation in progressive MS
But study findings still offer new insights to researchers seeking to dampen the immune system in the brain’s lining.